CALCIUM

Posology Adults For calcium deficiency states including malabsorption, the dosage should be tailored to the individual patient’s needs. 5g per day is recommended. 5g per day is normally required. In patients with adequate dietary calcium intake, 500mg daily may be sufficient.

5g of calcium per day is the recommended dosage for therapeutic supplementation. Special populations Elderly people The dose for adults can be applied for elderly patients. Paediatric population Calcium deficiency during the growth period: • Children aged 6 to 10 years: 1 tablet daily (500 mg per day), • Children aged over 10 years: 2 tablets daily (1 g per day).

Method of administration The tablets must be dissolved in a glass of water and the solution should then be drunk immediately after complete dissolution of the tablets.

The frequencies of adverse events are ranked according to the following:

Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000), Very rare (<1/10,000), not known (cannot be estimated from the available data). 4 or

15 mmol/kg/24 hours in children) or renal failure, or where there is evidence of stone formation in the urinary tract; adequate checks must be kept on urinary calcium excretion. If necessary the dosage should be reduced or calcium therapy discontinued.

The product should be administered with caution in patients with sarcoidosis because of possible increased metabolism of vitamin D to its active form. These patients should be monitored for serum and urinary calcium. Calcium and alkali intake from other sources (food, enriched foods, or other medicinal products) should be monitored when calcium carbonate is prescribed.

When high calcium doses are given together with alkaline substances such as carbonate, there is a risk of milk-alkali syndrome. 9). During long-term treatment, serum calcium levels should be followed and renal function should be monitored through measurements of serum creatinine.

5) and in patients with high tendency to calculus formation. In case of hypercalcaemia or signs of impaired renal function, treatment with calcium should be discontinued. 36 mg sorbitol per tablet. The additive effect of concomitantly administered products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account.

The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly. Sunset Yellow FCF (E 110) This medicine contains Sunset Yellow which may cause allergic reactions.

Sodium This medicine contains less than 1 mmol sodium (23 mg) per 5ml, that is to say essentially ‘sodium-free’.

Hypercalcaemia (eg. due to hyperparathyroidism, hypervitaminosis D, decalcifying tumours, severe renal failure, bone metastases). Severe hypercalciuria, calci-lithiasis and renal calculi. Long term immobilisation accompanied by hypercalciuria and/or hypercalcaemia.

1.